Annual EBITDA
Summary
- Current Value
- As of today, BAX annual EBITDA is $1.67B, down -0.59% on
- Historical Performance
- BAX annual EBITDA is down -44.57% over the past 3 years, down -36.61% over the past 5 years
- All-Time High Comparison
- BAX annual EBITDA is currently -57.40% below its historical high of $3.93B set on
- 3-Year Low Comparison
- BAX annual EBITDA is at its 3-year low
- Sector Comparison
- BAX annual EBITDA is higher than 95.11% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.67B | -0.6% | -44.6% | -36.6% | -55.0% | |
| Quarterly EBITDA | $351.00M | -18.4% | -38.7% | -46.5% | -61.4% | |
| TTM EBITDA | $1.59B | +1.1% | -44.7% | -39.4% | -53.7% | |
| Price | $17.99 | -41.8% | -58.5% | -78.5% | -43.6% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $11.24B | +5.7% | -22.5% | -3.7% | -13.9% | |
| Annual EPS | -$2.05 | -61.5% | +57.4% | -196.4% | -186.0% | |
| $693.00M | +0.9% | -57.7% | -61.9% | -77.1% | ||
| Annual Net Income | -$900.00M | -176.1% | +66.1% | -181.1% | -163.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.02B | N/A | -44.6% |
| 5Y | $3.02B | -44.6% | |
| All | $3.93B | -57.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.67B | at low | |
| 5Y | $1.67B | at low | |
| All | $252.40M | +563.2% |
EBITDA History
FAQ
What is the current annual EBITDA of BAX?
As of today, BAX annual EBITDA is $1.67B
What is 1-year change in BAX annual EBITDA?
BAX annual EBITDA is down -0.59% year-over-year
What is 3-year change in BAX annual EBITDA?
BAX annual EBITDA is down -44.57% over the past 3 years
How far is BAX annual EBITDA from its all-time high?
BAX annual EBITDA is currently -57.40% below its historical high of $3.93B set on December 31, 2011
How does BAX annual EBITDA rank versus sector peers?
BAX annual EBITDA is higher than 95.11% of companies in Healthcare sector
When is BAX next annual earnings release?
As of today, the next annual earnings release for BAX has not been scheduled
Quarterly EBITDA
Summary
- Current Value
- As of today, BAX quarterly EBITDA is $351.00M, down -1.68% on
- Historical Performance
- BAX quarterly EBITDA is down -18.37% year-over-year, down -38.74% over the past 3 years
- All-Time High Comparison
- BAX quarterly EBITDA is currently -79.45% below its historical high of $1.71B set on
- 3-Year Low Comparison
- BAX quarterly EBITDA is +17.79% above its 3-year low of $298.00M reached on
- Sector Comparison
- BAX quarterly EBITDA is higher than 94.14% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $351.00M | -1.7% | -18.4% | -38.7% | -46.5% | |
| Annual EBITDA | $1.67B | – | -0.6% | -44.6% | -36.6% | |
| TTM EBITDA | $1.59B | -4.7% | +1.1% | -44.7% | -39.4% | |
| Price | $17.99 | -19.2% | -41.8% | -58.5% | -78.5% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $2.70B | -9.2% | +2.9% | -23.1% | -8.3% | |
| Quarterly EPS | -$0.03 | +98.7% | -111.9% | -133.4% | -105.0% | |
| $106.00M | -9.4% | -42.1% | -59.2% | -75.8% | ||
| Quarterly Net Income | -$17.00M | +98.4% | -126.6% | -100.0% | -105.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $452.00M | -22.4% | |
| 3Y | $595.00M | -41.0% | |
| 5Y | $928.00M | -62.2% | |
| All | $1.71B | -79.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $351.00M | at low | |
| 3Y | $298.00M | +17.8% | |
| 5Y | $298.00M | +17.8% | |
| All | -$4.29B | +108.2% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of BAX?
As of today, BAX quarterly EBITDA is $351.00M
What is BAX quarterly EBITDA most recent change?
BAX quarterly EBITDA was down -1.68% on March 31, 2026
What is 1-year change in BAX quarterly EBITDA?
BAX quarterly EBITDA is down -18.37% year-over-year
How far is BAX quarterly EBITDA from its all-time high?
BAX quarterly EBITDA is currently -79.45% below its historical high of $1.71B set on September 30, 1988
How does BAX quarterly EBITDA rank versus sector peers?
BAX quarterly EBITDA is higher than 94.14% of companies in Healthcare sector
When is BAX next earnings release?
The next earnings release for BAX is on
TTM EBITDA
Summary
- Current Value
- As of today, BAX TTM EBITDA is $1.59B, down -4.73% on
- Historical Performance
- BAX TTM EBITDA is up +1.14% year-over-year, down -44.68% over the past 3 years
- All-Time High Comparison
- BAX TTM EBITDA is currently -59.52% below its historical high of $3.93B set on
- 3-Year Low Comparison
- BAX TTM EBITDA is +2.71% above its 3-year low of $1.55B reached on
- Sector Comparison
- BAX TTM EBITDA is higher than 94.98% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.59B | -4.7% | +1.1% | -44.7% | -39.4% | |
| Annual EBITDA | $1.67B | – | -0.6% | -44.6% | -36.6% | |
| Quarterly EBITDA | $351.00M | -1.7% | -18.4% | -38.7% | -46.5% | |
| Price | $17.99 | -19.2% | -41.8% | -58.5% | -78.5% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $11.32B | +0.7% | +5.1% | -21.7% | -4.2% | |
| TTM EPS | -$1.95 | -16.3% | -77.7% | +60.0% | -194.3% | |
| $612.00M | -11.2% | -15.6% | -60.8% | -65.7% | ||
| TTM Net Income | -$981.00M | -9.0% | -266.0% | +63.1% | -191.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.73B | -8.1% | |
| 3Y | $2.88B | N/A | -44.7% |
| 5Y | $3.11B | -48.9% | |
| All | $3.93B | -59.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.57B | N/A | +1.1% |
| 3Y | $1.55B | +2.7% | |
| 5Y | $1.55B | +2.7% | |
| All | -$3.45B | +146.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of BAX?
As of today, BAX TTM EBITDA is $1.59B
What is BAX TTM EBITDA most recent change?
BAX TTM EBITDA was down -4.73% on March 31, 2026
What is 1-year change in BAX TTM EBITDA?
BAX TTM EBITDA is up +1.14% year-over-year
How far is BAX TTM EBITDA from its all-time high?
BAX TTM EBITDA is currently -59.52% below its historical high of $3.93B set on December 31, 2011
How does BAX TTM EBITDA rank versus sector peers?
BAX TTM EBITDA is higher than 94.98% of companies in Healthcare sector
When is BAX next earnings release?
The next earnings release for BAX is on
EBITDA Formula
Data Sources & References
- BAX Official Website www.baxter.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/10456/000162828026007733/0001628280-26-007733-index.htm
- BAX Profile on Yahoo Finance finance.yahoo.com/quote/BAX
- BAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bax
